Validation of the lognormal model for prediction of long-term survival rates from short-term follow-up data in stages III and IV breast cancer: A 22-year follow-up study

Current Oncology

Volumn 10, Issue 3, 2003, Pages 191-194

  Tai, Patricia ^a,b   Yu, E ^c   Skarsgard, D ^b   Tonita, J ^b  

^a Allan Blair Cancer Centre   (Canada)

^b SASKATCHEWAN CANCER AGENCY   (Canada)

^c LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOG NORMAL MODEL; MAJOR CLINICAL STUDY; METHODOLOGY; MODEL; PREDICTION; SURVIVAL RATE; SURVIVAL TIME; VALIDATION PROCESS;

EID: 1542377412     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lea DE. The biological assay of carcinogens. Cancer Res 1945;5:633-40.
2. Pearlman AW. Breast cancer: influence of growth rate on prognosis and treatment evaluation. A study based on mastectomy scar recurrences. Cancer 1976;38:1826-33.
3. von Fournier D, Weber E, Hoeffken W, et al. Growth rate of 147 mammary carcinomas. Cancer 1980;45:2198-207.
4. McLaren CE, Brittenham GM, Hasselblad V. Analysis of the volume of red blood cells: application of the expectation maximisation algorithm to grouped data from the doubly truncated lognormal distribution. Biometrics 1986;42:143-58.
5. Berg JW. The distribution of cancer deaths in time: a survey test of the lognormal model. Br J Cancer 1965;19:695-711.
6. Mould RF, Heamden T, Palmer M, et al. Distribution of survival times of 12,000 head and neck cancer patients who died with their disease. Br J Cancer 1976;34:180-90.
7. Boag JW. Maximum likelihood estimates of the proportion of patients cured by cancer therapy. JR Stat Soc (Ser B) 1949; 11:15-53.
8. Tai P, Tonita J, Skarsgard D. A 20-year follow-up study of the long-term survival rate of limited stage small cell lung cancer patients [abstract]. Int J Radiat Oncol Biol Phys 2002; 54(Suppl):296.
9. Tai P, Tonita J, Yu E, et al. A 20-year follow-up study of the long-term survival of limited stage small cell lung cancer and an overview of prognostic and treatment factors. Int J Radiat Oncol Biol Phys 2003;56:626-33.
10. Rutqvist LE. On the utility of the lognormal model for analysis of breast cancer survival in Sweden 1961-1973. Br J Cancer 1985;52:875-83.
11. Rutqvist LE, Wallgren A, Nilsson BO. Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the cancer registry of Norway. Cancer 1984;53: 1793-800.
12. Gamel JW, Vogel RL, Valagussa P, et al. Parametric survival analysis of adjuvant therapy for stage II breast cancer. Cancer 1994;74:2483-90.
13. Gamel JW, Meyer JS, Feuer E, et al. The impact of stage and histology on the long-term clinical course of 163,808 patients with breast cancer. Cancer 1996;77:1459-64.
14. Haybittle JL. The estimation of the proportion of patients cured after treatment for cancer of the breast. Br J Radiol 1959; 32:725-33.
15. Tai P, Tonita J, Yu E, Skarsgard D. Application of the lognormal model for prediction of long-term survival rates from short-term follow-up data in advanced breast cancer. In: Proceedings of 29th Annual Scientific Meeting of Clinical Oncological Society of Australia (COSA) and the 2nd Sino-Australian-New Zealand Conference on Surgical Oncology; Sydney, Australia; November 28-30, 2002. 2002: 71.
16. Gamel JW, McLean IW, McCurdy JB. Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma. Cancer 1993;71:2299-305.
17. Mould RF, Boag JW. A test of several parametric statistical models for estimating success rate in the treatment of carcinoma cervix uteri. Br J Cancer 1975;32:529-50.
18. Maetani S, Tobe T, Hirakawa A, et al. Parametric survival analysis of gastric cancer patients. Cancer 1980;46:2709-16.
19. Tivey H. The prognosis for survival in chronic granulocytic and lymphocytic leukemia. Am J Roentgenol 1954;72:68-93.
20. Tai P, Tonita J, Yu E, Skarsgard D. Verification of lognormality of survival time for 42 cancer sites in the SEER database and early estimation of their statistical cure rates. In: Proceedings of 29th Annual Scientific Meeting of Clinical Oncological Society of Australia (COSA) and the 2nd Sino-Australian-New Zealand Conference on Surgical Oncology; Sydney, Australia; November 28-30, 2002. 2002: 110.
21. Boag JW. The presentation and analysis of the results of radiotherapy. Part I: Introduction. Br J Radiol 1948;21:128-38.
22. Boag JW. The presentation and analysis of the results of radiotherapy. Part II: Mathematical theory. Br J Radiol 1948; 21:189-203.
23. Mould RF, Lederman M, Tai P, et al. Methodology to predict long-term cancer survival from short-term data using Tobacco Cancer Risk and Absolute Cancer Cure Models. Phys Med Biol 2002;47:3893-924.
24. Mould RF, Tai THP, Wong JKM. Validation of lognormal prediction models for estimating long-term survival rates from short-term follow-up data for cancer of the prostate patients registered by the U.S.A. SEER Program. In: Bruggmoser G, Mould RF, Tai THP, Mate TP, editors. Prostate Cancer Review. Munich: W. Zuckschwerdt Verlag; 2003: 135-52.
25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.